-
To: STATE EDITORS
Contact: Elizabeth Funderburk of Consumer Healthcare Products Association, +1-202-429-9260, cell: +1-202-256-5677
-
To: NATIONAL EDITORS
Contact: Elizabeth Funderburk of the Consumer Healthcare Products Association, +1-202-429-9260 (w), +1-202-256-5677 (m)
-
To: MEDICAL EDITORS
Contact: Elizabeth Funderburk of Consumer Healthcare Products Association, +1-202-429-9260, or +1-202-256-5677
-
To: NATIONAL EDITORS
Contact: Elizabeth Funderburk and Virginia Cox of Consumer Healthcare Products Association, +1-202-429-9260
-
To: NATIONAL EDITORS
Contact: Elizabeth Funderburk or Mimi Pappas, both of Consumer Healthcare Products Association, +1-202-429-9260 (w), +1-202-256- 5677 (m)
-
To: HEALTH EDITORS
Contact: Elizabeth Funderburk and Virginia Cox, +1-202-429-9260 (work), +1-202-256-5677 (cell), both of the Consumer Healthcare Products Association
-
Makers of Over-the-Counter Single-Ingredient Pediatric Acetaminophen Products Already Taking Action to Help Parents Accurately Dose and Safely Store Medicines
WASHINGTON, May 18, 2011 /PRNewswire-USNewswire/ -- The Consumer Healthcare Products Association (CHPA), representing makers of over- the-counter (OTC) single-ingredient acetaminophen medicines for children, applauds the U.S. Food and Drug Administration (FDA) efforts to help parents and caregivers give their children the right amount of medicine. Today, the FDA's Nonprescription Drugs Advisory Committee and Pediatric Advisory Committee recommended enhancing the labels of all OTC single-ingredient pediatric acetaminophen products. If FDA acts on these recommendations, the revised labels would include:
-
To: HEALTH EDITORS
Contact: Elizabeth Funderburk, +1-202-429-9260 (work), +1-202- 256-5677 (cell), for the Consumer Healthcare Products Association
-
To: HEALTH EDITORS
Contact: Deborah Schnell, President, Sales & Strategic Planning, Healthy Advice Networks, +1-513-936-6852, dschnell@HealthyAdvice.com
-
FRANKFORT, Ky., Oct. 7, 2011 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) today urged members of the Kentucky General Assembly to adopt a new tool in the fight against illegal methamphetamine production and abuse, the Meth Offender Registry Block List. The block list would prevent convicted meth offenders from purchasing medicines containing pseudoephedrine (PSE) - medicines like Advil Cold and Sinus, Allegra-D, Claritin-D, Mucinex D, and Sudafed - without a doctor's prescription.
The Meth Offender Registry Block List would prevent convicted meth offenders, including convicted "smurfers", from purchasing PSE at the point of sale. A 2010 draft report from the Kentucky Legislative Research Commission estimates that the system would block 5,500 known criminals from p...